{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T20:58:10Z","timestamp":1771102690171,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN2012-2012S47X27"],"award-info":[{"award-number":["PRIN2012-2012S47X27"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bcp.2018.10.033","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T15:20:22Z","timestamp":1541085622000},"page":"286-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1"],"prefix":"10.1016","volume":"158","author":[{"given":"E.","family":"Albini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Coletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Greco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Pallotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mondanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gargaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Belladonna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Grohmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Macchiarulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3113-0572","authenticated-orcid":false,"given":"C.","family":"Orabona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2018.10.033_b0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trim.2006.09.017","article-title":"Tryptophan catabolism generates autoimmune-preventive regulatory T cells","volume":"17","author":"Fallarino","year":"2006","journal-title":"Transpl. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2018.10.033_b0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bcmd.2007.06.026","article-title":"Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism","volume":"40","author":"Puccetti","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"issue":"11","key":"10.1016\/j.bcp.2018.10.033_b0015","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells","volume":"176","author":"Fallarino","year":"2006","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"9","key":"10.1016\/j.bcp.2018.10.033_b0020","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1167\/iovs.05-1336","article-title":"Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor","volume":"48","author":"Ryu","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bcp.2018.10.033_b0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fimmu.2014.00230","article-title":"The role of placental tryptophan catabolism","volume":"5","author":"Sedlmayr","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2018.10.033_b0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2337\/db06-0617","article-title":"Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human islets","volume":"56","author":"Sarkar","year":"2007","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.bcp.2018.10.033_b0035","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1042\/CS20140392","article-title":"Role of indoleamine 2,3-dioxygenase in health and disease","volume":"129","author":"Yeung","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"issue":"7175","key":"10.1016\/j.bcp.2018.10.033_b0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature06471","article-title":"Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease","volume":"451","author":"Romani","year":"2008","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bcp.2018.10.033_b0045","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ni846","article-title":"CTLA-4-Ig regulates tryptophan catabolism in vivo","volume":"3","author":"Grohmann","year":"2002","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2018.10.033_b0050","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/all.12699","article-title":"Exaggerated IDO1 expression and activity in Langerhans cells from patients with atopic dermatitis upon viral stimulation: a potential predictive biomarker for high risk of Eczema herpeticum","volume":"70","author":"Staudacher","year":"2015","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.bcp.2018.10.033_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1084\/jem.20030633","article-title":"A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice","volume":"198","author":"Grohmann","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2018.10.033_b0060","article-title":"Targeting the IDO1\/TDO2-KYN-AhR pathway for cancer immunotherapy \u2013 challenges and opportunities","author":"Cheong","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2018.10.033_b0065","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.09.002","article-title":"Indoleamine 2,3-dioxygenase 1, increased in human gastric pre-neoplasia, promotes inflammation and metaplasia in mice and is associated with type II hypersensitivity\/autoimmunity","volume":"154","author":"El-Zaatari","year":"2018","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bcp.2018.10.033_b0070","first-page":"3142","article-title":"IDO1 and TGF-beta mediate protective effects of IFN-alpha in antigen-induced","volume":"197","author":"Chalise","year":"2016","journal-title":"Arthritis"},{"key":"10.1016\/j.bcp.2018.10.033_b0075","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fimmu.2017.00428","article-title":"The proteasome inhibitor bortezomib controls indoleamine 2,3-dioxygenase 1 breakdown and restores immune regulation in autoimmune diabetes","volume":"8","author":"Mondanelli","year":"2017","journal-title":"Front. Immunol."},{"issue":"46","key":"10.1016\/j.bcp.2018.10.033_b0080","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.1073\/pnas.1014465107","article-title":"Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism","volume":"107","author":"Nguyen","year":"2010","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.bcp.2018.10.033_b0085","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"10","key":"10.1016\/j.bcp.2018.10.033_b0090","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","article-title":"T cell apoptosis by tryptophan catabolism","volume":"9","author":"Fallarino","year":"2002","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.bcp.2018.10.033_b0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.molmed.2008.11.006","article-title":"TGF-beta and kynurenines as the key to infectious tolerance","volume":"15","author":"Belladonna","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"52","key":"10.1016\/j.bcp.2018.10.033_b0100","doi-asserted-by":"crossref","first-page":"20828","DOI":"10.1073\/pnas.0810278105","article-title":"SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis","volume":"105","author":"Orabona","year":"2008","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.bcp.2018.10.033_b0105","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ni.2077","article-title":"Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells","volume":"12","author":"Pallotta","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2018.10.033_b0110","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2119\/molmed.2012.00029","article-title":"Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase","volume":"18","author":"Orabona","year":"2012","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2018.10.033_b0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/jcmm.12954","article-title":"Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1","volume":"21","author":"Albini","year":"2017","journal-title":"J. Cell Mol. Med."},{"issue":"52","key":"10.1016\/j.bcp.2018.10.033_b0120","doi-asserted-by":"crossref","first-page":"19678","DOI":"10.1073\/pnas.0603873103","article-title":"Why molecules move along a temperature gradient","volume":"103","author":"Duhr","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2018.10.033_b0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejmech.2017.09.044","article-title":"Fragment-based approach to identify IDO1 inhibitor building blocks","volume":"141","author":"Coletti","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2018.10.033_b0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1517\/17460441.2.4.469","article-title":"Ligand efficiency indices for effective drug discovery","volume":"2","author":"Abad-Zapatero","year":"2007","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.bcp.2018.10.033_b0135","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/acs.jmedchem.5b01390","article-title":"Important hydrogen bond networks in indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor design revealed by crystal structures of imidazoleisoindole derivatives with IDO1","volume":"59","author":"Peng","year":"2016","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2018.10.033_b0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucl. Acids Res."},{"issue":"3","key":"10.1016\/j.bcp.2018.10.033_b0145","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.4049\/jimmunol.156.3.1095","article-title":"Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo","volume":"156","author":"Fallarino","year":"1996","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"2","key":"10.1016\/j.bcp.2018.10.033_b0150","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.pep.2004.06.025","article-title":"Optimised expression and purification of recombinant human indoleamine 2,3-dioxygenase","volume":"37","author":"Austin","year":"2004","journal-title":"Protein Expr. Purif."},{"issue":"10","key":"10.1016\/j.bcp.2018.10.033_b0155","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/jcmm.12360","article-title":"Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes","volume":"18","author":"Pallotta","year":"2014","journal-title":"J. Cell Mol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2018.10.033_b0160","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nm1563","article-title":"Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy","volume":"13","author":"Grohmann","year":"2007","journal-title":"Nat. Med."},{"issue":"13","key":"10.1016\/j.bcp.2018.10.033_b0165","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1073\/pnas.1719190115","article-title":"Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form","volume":"115","author":"Nelp","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.bcp.2018.10.033_b0170","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1021\/jm300260v","article-title":"Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition","volume":"55","author":"Rohrig","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2018.10.033_b0175","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejmech.2014.06.078","article-title":"Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors","volume":"84","author":"Rohrig","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2018.10.033_b0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0378-1119(91)90154-4","article-title":"Cloning and expression of a cDNA encoding mouse indoleamine 2,3-dioxygenase","volume":"105","author":"Habara-Ohkubo","year":"1991","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.bcp.2018.10.033_b0185","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)77982-4","article-title":"Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity","volume":"263","author":"Takikawa","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2018.10.033_b0190","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.immuni.2017.01.005","article-title":"A relay pathway between arginine and tryptophan metabolism confers immunosuppressive properties on dendritic cells","volume":"46","author":"Mondanelli","year":"2017","journal-title":"Immunity"},{"issue":"7508","key":"10.1016\/j.bcp.2018.10.033_b0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nature13323","article-title":"Aryl hydrocarbon receptor control of a disease tolerance defence pathway","volume":"511","author":"Bessede","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2018.10.033_b0200","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/ncomms2874","article-title":"High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway","volume":"4","author":"Volpi","year":"2013","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2018.10.033_b0205","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1182\/blood-2005-10-4077","article-title":"Toward the identification of a tolerogenic signature in IDO-competent dendritic cells","volume":"107","author":"Orabona","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bcp.2018.10.033_b0210","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1002\/eji.200535289","article-title":"Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12","volume":"35","author":"Orabona","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2018.10.033_b0215","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/eji.1830240631","article-title":"Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity","volume":"24","author":"Puccetti","year":"1994","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2018.10.033_b0220","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1084\/jem.20092627","article-title":"MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity","volume":"207","author":"Irla","year":"2010","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.bcp.2018.10.033_b0225","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/ni.2088","article-title":"IDO: more than an enzyme","volume":"12","author":"Chen","year":"2011","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2018.10.033_b0230","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2018.10.033_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2018.08.005","article-title":"Immune checkpoint molecules, personalized immunotherapy, and autoimmune diabetes","author":"Orabona","year":"2018","journal-title":"Trends Mol. Med."},{"issue":"24","key":"10.1016\/j.bcp.2018.10.033_b0240","doi-asserted-by":"crossref","first-page":"9421","DOI":"10.1021\/acs.jmedchem.5b00326","article-title":"Challenges in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors","volume":"58","author":"Rohrig","year":"2015","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2018.10.033_b0245","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.trecan.2017.11.005","article-title":"Inflammatory reprogramming with IDO1 inhibitors: turning immunologically unresponsive 'cold' tumors 'hot'","volume":"4","author":"Prendergast","year":"2018","journal-title":"Trends Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2018.10.033_b0250","first-page":"307","article-title":"IDO takes a blow","volume":"17","author":"Mullard","year":"2018","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"6389","key":"10.1016\/j.bcp.2018.10.033_b0255","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1126\/science.360.6389.588","article-title":"A new cancer immunotherapy suffers a setback","volume":"360","author":"Garber","year":"2018","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"10.1016\/j.bcp.2018.10.033_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-Repopulating Cells Induce PD-1 Expression in CD8(+) T Cells by Transferring Kynurenine and AhR Activation","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2018.10.033_b0265","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.taap.2017.03.012","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor","volume":"323","author":"Moyer","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2018.10.033_b0270","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2337\/db17-1281","article-title":"Loss of IDO1 expression from human pancreatic beta-cells precedes their destruction during the development of type 1 diabetes","volume":"67","author":"Anquetil","year":"2018","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.bcp.2018.10.033_b0275","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96244","article-title":"Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes","volume":"3","author":"Orabona","year":"2018","journal-title":"JCI Insight"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218304672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218304672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:03:50Z","timestamp":1762095830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218304672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":55,"alternative-id":["S0006295218304672"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.10.033","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}